Committed to understanding #PancreaticCancer and #LungCancer in order to develop novel, targeted therapeutic strategies. @YaleCancer @YaleMed
New Haven, CT
Joined February 2021
- Tweets87
- Following76
- Followers313
- Likes60
Congratulations to Drs. Luisa Escobar-Hoyos & Peter Glazer on their 2025 Yale Cancer Center Award for Translational Science. Their work pioneers a new technology for targeted RNA delivery into cancer cells, a game-changer for treating hard-to-reach tumors.
ALT https://medicine.yale.edu/news-article/standout-research-clinical-care-and-staff-support-recognized/?utm_source=beatrix_newsletter&utm_medium=email&utm_campaign=YSM_News_and_Recognition_02-04-26
Grateful to the @PershingSqFdn for inviting me to the Prix Galien USA gala celebrating breakthroughs in biomedical research! Honored to represent early-career scientists working to advance precision oncology and pancreatic cancer research. #PrixGalien #CancerResearch
Escobar-Hoyos Lab retweeted
Pancreatic cancer researcher and professor Luisa Escobar-Hoyos, MSc, PhD, saw her work hit too close to home when her mother Luz, also a cancer researcher and professor, was diagnosed with one of the world’s toughest cancers. 💜 bit.ly/3ItF5Vk
So, when Dr. Escobar-Hoyos had the opportunity to speak at a Congressional briefing on the importance of federally funded cancer research, she shared how her lab’s research depended on funding from our government — and how her work had become more personal than ever before. 🔬🧫
@Escobar_Lab @YaleMed @YaleCancer
Escobar-Hoyos Lab retweeted
Yale researchers engineered an antibody, #TMAB3, to carry immune-activating RNA directly to hard-to-treat tumors-shrinking tumors, ⬆️ survival, + avoiding healthy tissue. “This lays the foundation for personalized, tumor-targeted RNA therapies,”@Escobar_Lab.
yalecancercenter.org/news-ar…
@SmilowCancer @ScienceTM
Excited to announce our newest paper in @ScienceTM about our tumor-specific, nucleic acid-binding TMAB3 antibody! Work done in collaboration w/ the #Glazerlab and co-led by our very own post-docs Dr. Diana Martinez-Saucedo & @nanamedici @YaleCancer @YaleMed
We found that TMAB3, combined with an RNA that stimulates the innate immune response, can penetrate tumors and inhibit tumor growth in #PDAC #medulloblastoma and #melanoma. Meaning TMAB3 has potential as a tumor-specific delivery mechanism for DNA- and RNA-based therapies.
Read it here: science.org/doi/10.1126/scit…
Read a short summary: medicine.yale.edu/news-artic…
Grateful to be one of the recipients for the Pershing Square Sohn Cancer Prize from @psscra! It will greatly help our work to develop a novel vaccine for pancreatic cancer. Work was led by our post docs @nanamedici
and Diana Martinez-Saucedo! @YaleMed @YaleCancer
Dr. Luisa Escobar-Hoyos and the @Escobar_Lab at @YaleMed are developing a novel pancreatic cancer vaccine that leverages the body's existing immunity to bacteria to target and destroy pancreatic tumors. Congrats, Luisa! vimeo.com/1085105016
Escobar-Hoyos Lab retweeted
Please join us in celebrating the 2025 Pershing Square Sohn Cancer Prize winners! This year’s six scientists have been selected for their bold ideas and potential to transform cancer research. The winners are: pershingsquarephilanthropies…
Escobar-Hoyos Lab retweeted
Thank you to all those who joined our lunch briefing earlier this week, especially to our guest speakers from @ACSCAN, @theNCI, @WhiteHouse, @DrRobWinn from @VCUMassey, & @YaleMed! Together, as #OneVoiceAgainstCancer, we can work towards better cancer care for all & save lives!💗
Grateful for the opportunity to participate in the @OVACinfo panel on Capitol Hill to advocate for increased #cancer funding! @YaleCancer @YaleMed @YNHH @YaleRadOnc @SmilowCancer
Escobar-Hoyos Lab retweeted
Tomorrow in Washington, DC, Luisa Escobar-Hoyos, MSc, PhD @Escobar_Lab will be speaking in a Congressional briefing organized by @OVACInfo to advocate for increased funding for #cancerresearch.
@YaleCancer @YaleMed @YNHH @YaleRadOnc
MD-PhD student @yugawad presented a wonderful poster about the role of #K17 solubility in #pancreaticcancer at #AACRpan24
Escobar-Hoyos Lab retweeted
Congratulations @MuzumdarLab, @Escobar_Lab, @CathyCGarcia1, @ChristianFRuiz, @nanamedici, and Dr. Diana Martinez-Saucedo on your presentations and posters at #AACRpan24. We're proud of your work advancing the field of #PancreaticCancer.
@SmilowCancer @YaleMed @YNHH @AACR
Postdoctoral fellow @nanamedici gave a fabulous lightning talk and poster about her work of #SF3B1 and #RBM10, two RNA splicing factors, in #pancreaticcancer #AACRpan24
MD-PhD student @yugawad presented a wonderful poster about the role of #K17 solubility in #pancreaticcancer at #AACRpan24
Great talks by @CathyCGarcia1 and @ChristianFRuiz from the @MuzumdarLab about their amazing work looking at beta-cell driven #PDAC and fatty acid metabolism in #PDAC at #AACRpan24 @YaleMed @YaleCancer @YaleGenetics
Great talks by @CathyCGarcia1 and @ChristianFRuiz from the @MuzumdarLab about their amazing work looking at beta-cell driven #PDAC and fatty acid metabolism in #PDAC at #AACRpan24 @YaleMed @YaleCancer @YaleGenetics
What an amazing lightning talk by @dimartzs at #AACRpan24. Technical issues and no slides didn’t stop her from promoting her work on TMAB, a novel antibody that can deliver nucleic acids to tumors w/ #GlazerLab! @YaleCancer @YaleMed
